MindBio Therapeutics Corp. (CSE:MBIO)
0.0900
-0.0050 (-5.26%)
Nov 20, 2026, 1:49 PM EST
MindBio Therapeutics Market Cap
MindBio Therapeutics has a market cap or net worth of CAD 655.48 thousand as of November 20, 2026. It is the 50,428th most valuable company in the world and the 2,566th biggest in Canada. Its market cap has decreased by 74.35% in one year.
Market Cap
655.48K
Enterprise Value
2.54M
Revenue
n/a
Global Rank
Country Rank
#2,566 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since May 5, 2023, MindBio Therapeutics's market cap has decreased from 79.83M to 655.48K, a decrease of -99.18%. That is a compound annual growth rate of -74.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 655.48K | -89.06% |
| Dec 31, 2025 | 5.99M | 109.60% |
| Dec 31, 2024 | 2.86M | -14.04% |
| Dec 27, 2023 | 3.33M | -95.83% |
| May 5, 2023 | 79.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grey Matters Health | 3.45M |
| Quest PharmaTech | 3.38M |
| ASEP Medical Holdings | 3.17M |
| BioVaxys Technology | 3.09M |
| Universal Ibogaine | 1.56M |
| Doseology Sciences | 881.28K |
| Waverley Pharma | 540.00K |
| Vaxil Bio | 458.16K |